Shares of Idera Pharmaceuticals (IDRA) soared trading on Monday after the FDA granted orphan designation to the company’s treatment of Waldenstrom’s macroglobulinemia. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) belongs to Healthcare sector. Its weekly performance is 9.22%. On last trading day company shares ended up $4.50. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) distance from 50-day simple moving average (SMA50) is 47.54%. Comcast (NASDAQ:CMCSA) SVP Arthur R. Block sold 7,407 … Continue reading 5 Stock in Different Moves: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), Comcast Corporation (NASDAQ:CMCSA), NCI, Inc. (NASDAQ:NCIT), PNM Resources, Inc. (NYSE:PNM), PacWest Bancorp (NASDAQ:PACW)